CL
Carolyn J Logan
President & CEODirector

Carolyn J Logan insider trades: Salix Pharmaceuticals (SLXP) stock buys and sales

President & CEO, Salix Pharmaceuticals Last trade Jun 26, 2014 39 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2006
1
Company
last trade 2014

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Carolyn reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 26, 2014SLXP↓ Sell$6.5M
Dec 20, 2012SLXP↓ Sell$1.1M
Jun 28, 2012SLXP↓ Sell$6.2M
Sep 21, 2010SLXP↓ Sell$593K
Sep 14, 2009SLXP↓ Sell$207K
Nov 16, 2007SLXP↑ Buy$73K
Jul 3, 2007SLXP↓ Sell$70K
May 9, 2006SLXP↑ Buy$99K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Carolyn J Logan's insider trades

Carolyn J Logan is President & CEO at Salix Pharmaceuticals (SLXP). Since May 9, 2006, Carolyn has reported 2 open-market purchases worth $173K and 6 sales worth $14.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (12 filings), grants and awards (10 filings), shares withheld for taxes (10 filings), gifts (8 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SLXP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.